Paper34716976
How translational modeling in oncology needs to get the mechanism just right.
Yates JWT and 1 other. Clin Transl Sci, 2022. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. How translational modeling in oncology needs to get the mechanism just right. Papers, record 34716976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34716976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Humans | |
| Medical Oncology |
Source PubMed
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31338741 | Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to. | Bull Math Biol | 2019 | https://conductscience.org/library/papers/31338741 | PubMed |
| 2 | 29761883 | Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance. | CPT Pharmacometrics Syst Pharmacol | 2018 | https://conductscience.org/library/papers/29761883 | PubMed |
| 3 | 1004590 | Predicting the course of Gompertzian growth. | Nature | 1976 | https://conductscience.org/library/papers/1004590 | PubMed |
| 4 | 2250141 | A nonlinear structured population model of tumor growth with quiescence. | J Math Biol | 1990 | https://conductscience.org/library/papers/2250141 | PubMed |
| 5 | 20424896 | Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice. | J Pharmacokinet Pharmacodyn | 2010 | https://conductscience.org/library/papers/20424896 | PubMed |
| 6 | 8993512 | Schedule-dependent efficacy of camptothecins in models of human cancer. | Ann N Y Acad Sci | 1996 | https://conductscience.org/library/papers/8993512 | PubMed |
| 7 | 34716976 | How translational modeling in oncology needs to get the mechanism just right. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/34716976 | PubMed |
| 8 | 28722322 | Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014). | CPT Pharmacometrics Syst Pharmacol | 2017 | https://conductscience.org/library/papers/28722322 | PubMed |
| 9 | 5965750 | Growth rate and radiosensitivity of human tumours. I. Growth rate of human tumours. | Eur J Cancer (1965) | 1966 | https://conductscience.org/library/papers/5965750 | PubMed |
| 10 | 21819622 | Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies. | BMC Cancer | 2011 | https://conductscience.org/library/papers/21819622 | PubMed |
| 11 | 30739743 | Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. | Lancet | 2019 | https://conductscience.org/library/papers/30739743 | PubMed |
| 12 | 29470495 | Reproducibility of preclinical animal research improves with heterogeneity of study samples. | PLoS Biol | 2018 | https://conductscience.org/library/papers/29470495 | PubMed |
| 13 | 25470047 | Cancer: Resistance through repopulation. | Nature | 2015 | https://conductscience.org/library/papers/25470047 | PubMed |
| 14 | 14219541 | DYNAMICS OF TUMOR GROWTH. | Br J Cancer | 1964 | https://conductscience.org/library/papers/14219541 | PubMed |
| 15 | 31375756 | A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade. | Sci Rep | 2019 | https://conductscience.org/library/papers/31375756 | PubMed |
| 16 | 26310312 | Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738. | Sci Rep | 2015 | https://conductscience.org/library/papers/26310312 | PubMed |
| 17 | 6387060 | The importance of dose intensity in chemotherapy of metastatic breast cancer. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6387060 | PubMed |
| 18 | 3191483 | A Gompertzian model of human breast cancer growth. | Cancer Res | 1988 | https://conductscience.org/library/papers/3191483 | PubMed |
| 19 | 24850445 | Model-based meta-analysis for quantifying Paclitaxel dose response in cancer patients. | CPT Pharmacometrics Syst Pharmacol | 2014 | https://conductscience.org/library/papers/24850445 | PubMed |
| 20 | 7634381 | Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7634381 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38751464 | Features and applications of Ehrlich tumor model in cancer studies: a literature review. | Transl Breast Cancer Res | 2023 | https://conductscience.org/library/papers/38751464 | PubMed |
| 37930506 | Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model. | J Pharmacokinet Pharmacodyn | 2024 | https://conductscience.org/library/papers/37930506 | PubMed |
| 37771203 | Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37771203 | PubMed |
| 35189161 | Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35189161 | PubMed |
| 34716976 | How translational modeling in oncology needs to get the mechanism just right. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/34716976 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34716976
GET https://conductscience.org/api/papers/v1/34716976/references?page=2